Table 1 Demographic and clinical baseline characteristics of 99 children with intra-thoracic TB and samples analyzed for transcriptional biomarkers (dcRT-MLPA).
Baseline characteristics | Distribution | |
|---|---|---|
Sociodemographics and medical history | ||
 Gender | Male (n) | 45 |
 Age | mean age in months (St.dev) | 107,8 (46,0) |
|  | ≤5 years (n) | 16 |
|  | >5 to ≤10 years (n) | 40 |
| Â | >10 to 16 years (n) | 43 |
 Known contact with TB patient (n) | 35 | |
 BCG vaccination | ||
| Â | Yes (n) | 82 |
| Â | No (n) | 16 |
| Â | Not known (n) | 1 |
Symptoms | ||
 Cough ≥2 weeks (n) | 63 | |
 Fever (n) | 77 | |
 Weight loss (n) | 74 | |
 Loss of appetite (n) | 74 | |
Anthropometric data | ||
 Body Mass Index Z-score, mean (St.dev) | −2,28 (1,46) | |
 Weight-for-age Z-score, mean (St.dev) | −2,54 (1,68) | |
Diagnosis and treatment | Â | |
 Smear positivityˇ (n) | 13 | |
 Mtb-culture positive° (n) | 41 | |
 NTM culture positivea (n) | 7 | |
 Finding on Chest X-ray |  | |
| Â | uncomplicated LN disease (n) | 17 |
| Â | LN disease with collapse (n) | 2 |
| Â | progressive primary disease (n) | 49 |
| Â | primary pulmonary complex (n) | 11 |
| Â | miliary TB (n) | 1 |
| Â | pleural effusion (n) | 8 |
| Â | cavitation disease (n) | 10 |
| Â | calcification (n) | 1 |
 Lymph node swelling (n) | 19 | |
 Tuberculin Skin Test |  | |
| Â | mean in mm (St.dev) | 15,1 (8,1) |
|  | ≥10 mm (n) | 96 |
 QuantiFERON Gold In-tube | ||
| Â | Positive (n) | 76 |
| Â | Negative (n) | 22 |
| Â | Indeterminate (n) | 1 |
 Anti-tuberculosis treatment | ||
| Â | Category 1 b (n) | 75 |
| Â | Category 3 c (n) | 24 |
 Micronutrient supplement | ||
| Â | Micronutrients and Zinc (n) | 25 |
| Â | Micronutrients (n) | 21 |
| Â | Zinc (n) | 26 |
| Â | Placebo (n) | 27 |